Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6135755 | Microbes and Infection | 2014 | 6 Pages |
Abstract
Staphylococcus aureus is a leading cause of bacterial infections. Strains of community-associated methicillin-resistant S. aureus (CA-MRSA), such as USA300, display enhanced virulence and fitness. Patients suffering from iron overload diseases often undergo iron chelation therapy with deferoxamine mesylate (DFO). Here, we show that USA300 uses this drug to acquire iron. We further demonstrate that mice administered DFO I.P., versus those not administered DFO, had significantly higher bacterial burden in livers and kidneys after I.V. challenge with USA300, associated with increased abscess formation and tissue destruction. The virulence of USA300 mutants defective for DFO uptake was not affected by DFO treatment.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Andrew J. Arifin, Mélissa Hannauer, Ian Welch, David E. Heinrichs,